'Poorly designed': ICMR distances itself from BHU's study on Covaxin businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
Coinciding with AstraZeneca’s acknowledgment of rare side effects of its vaccine, which was sold as Covishield in India, in UK courts earlier this year, a study by BHU researchers has suggested that those who have received the Covaxin vaccine may not find relief, as its side effects are
Bharat Biotech, University Of Sydney To Advance Vaccine Research Collaboration menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Leading vaccine-maker Bharat Biotech and the University of Sydney Infectious Diseases Institute (Sydney ID) on Tuesday announced a Memorandum of Understanding (MoU) to advance vaccine research initiatives, strengthen academic-industry .